Alert: Major Price Advance (4/3/24)-Vanda Pharmaceuticals Inc (NASDAQ: VNDA).


On 4/3/24, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock enjoyed a major increase of 29.2%, closing at $5.05. Moreover, this advance was accompanied by exceptionally high trading volume at 2565% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 30.5% during the last week.


Current PriceTarget Research Rating

Reflecting future returns on capital that are forecasted to be in line with the cost of capital, VNDA is expected to be Value Creation neutral.

Vanda Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Vanda Pharmaceuticals has a good Appreciation Score of 78 but a poor Power Rating of 16, and the Low Neutral Value Trend Rating results.

Rating Review

In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.